D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 74 Citations 18,077 286 World Ranking 458 National Ranking 13

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Bacteria
  • Internal medicine

His scientific interests lie mostly in Microbiology, Antibacterial agent, Ciprofloxacin, Antibiotic resistance and Pharmacology. His studies in Microbiology integrate themes in fields like Ceftazidime and Klebsiella pneumoniae. His Antibacterial agent research incorporates themes from Multiple drug resistance and Drug resistance.

His Antibiotic resistance study combines topics in areas such as Penicillin, Streptococcus pneumoniae and Ceftriaxone. His studies deal with areas such as Minimum inhibitory concentration, Anaerobic bacteria and Avibactam as well as Pharmacology. His work deals with themes such as Cefepime and Imipenem, which intersect with Meropenem.

His most cited work include:

  • Comparative review of the carbapenems. (394 citations)
  • Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States (325 citations)
  • Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001 (320 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Microbiology, Antibacterial agent, Broth microdilution, Antimicrobial and Streptococcus pneumoniae. The concepts of his Microbiology study are interwoven with issues in Pseudomonas aeruginosa and Klebsiella pneumoniae. His research integrates issues of Vancomycin, Minimum inhibitory concentration, Aminoglycoside and Levofloxacin in his study of Antibacterial agent.

His work investigates the relationship between Broth microdilution and topics such as Meropenem that intersect with problems in Colistin and Tigecycline. His Streptococcus pneumoniae study combines topics from a wide range of disciplines, such as Haemophilus influenzae, Virology, Penicillin, Staphylococcus aureus and Ceftriaxone. James A. Karlowsky interconnects Pharmacology and Bacteria in the investigation of issues within Antibiotics.

He most often published in these fields:

  • Microbiology (83.99%)
  • Antibacterial agent (22.47%)
  • Broth microdilution (22.47%)

What were the highlights of his more recent work (between 2018-2021)?

  • Microbiology (83.99%)
  • Broth microdilution (22.47%)
  • Pseudomonas aeruginosa (18.82%)

In recent papers he was focusing on the following fields of study:

James A. Karlowsky mainly investigates Microbiology, Broth microdilution, Pseudomonas aeruginosa, Klebsiella pneumoniae and Imipenem. His study in Microbiology is interdisciplinary in nature, drawing from both Bacilli and Escherichia coli. His Broth microdilution study incorporates themes from Ciprofloxacin, Clindamycin, Cefepime, Genotype and Drug resistance.

His work carried out in the field of Pseudomonas aeruginosa brings together such families of science as Multiple drug resistance, Enterobacteriaceae and Intensive care. His research in Klebsiella pneumoniae intersects with topics in Amikacin and Antibiotic resistance, Meropenem. The study incorporates disciplines such as Ceftazidime and Serratia marcescens in addition to Imipenem.

Between 2018 and 2021, his most popular works were:

  • Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli (94 citations)
  • In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015. (46 citations)
  • Microbiology and Preclinical Review of Omadacycline. (18 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Internal medicine

The scientist’s investigation covers issues in Microbiology, Broth microdilution, Pseudomonas aeruginosa, Imipenem and Bacilli. His research in Ceftolozane, Tazobactam, Colistin, Enterococcus and Antimicrobial are components of Microbiology. His biological study spans a wide range of topics, including Sulfamethoxazole, Staphylococcus haemolyticus, Klebsiella pneumoniae and Trimethoprim.

The various areas that he examines in his Imipenem study include Ceftazidime and Multiple drug resistance. James A. Karlowsky has included themes like Acinetobacter baumannii and Pharmacology in his Ceftazidime study. His Bacilli research is multidisciplinary, incorporating elements of Enterobacteriaceae and Cephalosporin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comparative review of the carbapenems.

George G Zhanel;Ryan Wiebe;Leanne Dilay;Kristjan Thomson.
Drugs (2007)

649 Citations

Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States

James A. Karlowsky;Laurie J. Kelly;Clyde Thornsberry;Mark E. Jones.
Antimicrobial Agents and Chemotherapy (2002)

500 Citations

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

James A. Karlowsky;Deborah C. Draghi;Mark E. Jones;Clyde Thornsberry.
Antimicrobial Agents and Chemotherapy (2003)

488 Citations

Rapid Identification of Fungi by Using the ITS2 Genetic Region and an Automated Fluorescent Capillary Electrophoresis System

Christine Y. Turenne;Steven E. Sanche;Daryl J. Hoban;James A. Karlowsky.
Journal of Clinical Microbiology (1999)

419 Citations

Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

Daniel F. Sahm;Clyde Thornsberry;David C. Mayfield;Mark E. Jones.
Antimicrobial Agents and Chemotherapy (2001)

395 Citations

Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)

Mark E Jones;Deborah C Draghi;Clyde Thornsberry;James A Karlowsky.
Annals of Clinical Microbiology and Antimicrobials (2004)

360 Citations

Review of macrolides and ketolides: focus on respiratory tract infections.

George G. Zhanel;Maria Dueck;Daryl J. Hoban;Lavern M. Vercaigne.
Drugs (2001)

355 Citations

The glycylcyclines: a comparative review with the tetracyclines.

George G Zhanel;Kristen Homenuik;Kim Nichol;Ayman Noreddin.
Drugs (2004)

353 Citations

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

George G. Zhanel;George G. Zhanel;Christopher D. Lawson;Heather Adam;Heather Adam;Frank Schweizer.
Drugs (2013)

349 Citations

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

George G. Zhanel;Tamiko L. Hisanaga;Nancy M. Laing;Melanie R. DeCorby.
International Journal of Antimicrobial Agents (2006)

321 Citations

Editorial Boards

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing James A. Karlowsky

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 120

George G. Zhanel

George G. Zhanel

University of Manitoba

Publications: 118

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 100

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 99

Michael J. Rybak

Michael J. Rybak

Eugene Applebaum College of Pharmacy and Health Sciences

Publications: 79

Robert K. Flamm

Robert K. Flamm

Janssen (Belgium)

Publications: 79

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 63

Rodrigo E. Mendes

Rodrigo E. Mendes

JMI Laboratories

Publications: 57

Daryl J. Hoban

Daryl J. Hoban

University of Manitoba

Publications: 55

James R. Johnson

James R. Johnson

University of Minnesota

Publications: 50

Matthew E. Falagas

Matthew E. Falagas

Alfa Institute of Biomedical Sciences

Publications: 47

Mariana Castanheira

Mariana Castanheira

JMI Laboratories

Publications: 46

Jason A. Roberts

Jason A. Roberts

Royal Brisbane and Women's Hospital

Publications: 35

Donald E. Low

Donald E. Low

University of Toronto

Publications: 34

Po-Ren Hsueh

Po-Ren Hsueh

National Taiwan University

Publications: 34

Robert A. Bonomo

Robert A. Bonomo

United States Department of Veterans Affairs

Publications: 33

Trending Scientists

Yair Weiss

Yair Weiss

Hebrew University of Jerusalem

Jeom Kee Paik

Jeom Kee Paik

University College London

Jeremy Schwartzentruber

Jeremy Schwartzentruber

Wellcome Sanger Institute

Tom Brereton

Tom Brereton

Butterfly Conservation

Philip A. Barker

Philip A. Barker

Lancaster University

Robert Verpoorte

Robert Verpoorte

Leiden University

Michael J. O’Donohue

Michael J. O’Donohue

Federal University of Toulouse Midi-Pyrénées

Renato A. Mortara

Renato A. Mortara

Federal University of Sao Paulo

Sharon A. Savage

Sharon A. Savage

National Institutes of Health

Maria Bokarewa

Maria Bokarewa

University of Gothenburg

Toshihiro Kogure

Toshihiro Kogure

University of Tokyo

Steve M. Jex

Steve M. Jex

Bowling Green State University

Thomas R. Przybeck

Thomas R. Przybeck

Washington University in St. Louis

Bruno Niederle

Bruno Niederle

Medical University of Vienna

George A. Beller

George A. Beller

University of Virginia

Robin S. Roberts

Robin S. Roberts

McMaster University

Something went wrong. Please try again later.